Adenuric - search results

European Union - English - EMA (European Medicines Agency)

adenuric

menarini international operations luxembourg s.a. (miol) - febuxostat - gout - antigout preparations - 80 mg strength:treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).adenuric is indicated in adults.120 mg strength:adenuric is indicated for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).adenuric is indicated for the prevention and treatment of hyperuricaemia in adult patients undergoing chemotherapy for haematologic malignancies at intermediate to high risk of tumor lysis syndrome (tls).adenuric is indicated in adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

adenuric

a. menarini new zealand pty ltd - febuxostat 120mg; - film coated tablet - 120 mg - active: febuxostat 120mg excipient: colloidal silicon dioxide croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 85f42129 - treatment of chronic hyperuricaemia in patients with gout (including a history, or presence of, tophus and/or gouty arthritis). adenuric is indicated in adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

adenuric

a. menarini new zealand pty ltd - febuxostat 80mg; - film coated tablet - 80 mg - active: febuxostat 80mg excipient: colloidal silicon dioxide croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 85f42129 - treatment of chronic hyperuricaemia in patients with gout (including a history, or presence of, tophus and/or gouty arthritis). adenuric is indicated in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

adenuric febuxostat 80 mg tablets blister pack

a menarini australia pty ltd - febuxostat, quantity: 80 mg - tablet - excipient ingredients: microcrystalline cellulose; hyprolose; croscarmellose sodium; magnesium stearate; silicon dioxide; lactose monohydrate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - treatment of chronic symptomatic hyperuricaemia in conditions where urate deposition has already occurred (gouty arthritis and/or tophus formation) in adults with gout.